Relationship Between Kallikrein Release and Factor XII in Normal Persons and Carriers of the Hageman Trait

Summary

In four healthy subjects with Factor XII levels equal to or below 50% (selected at random from 100 persons) the release of Kallikrein was studied in order to establish the relationship between the above data and those found in four Hageman trait carriers showing levels of Factor XII above the lowest normal limits. It was found that for similar amounts of Hageman activity three of the carriers showed significantly less release of Kallikrein than the control subjects in whom it was normal.

The conclusion was reached that the additional determination of the amount of Kallikrein released may be of value in the detection of carriers of the Hageman trait.

• References

• 1 Biggs RM. 1972. Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford: pp 613-616
• 2 Colman RW, Mason IW, Sherry S. 1969; The Kallikreinogen-Kallikrein system of human plasma. Annals of Internal Medicine 71: 763
• 3 Colman RW, Mauler L, Sherry S. 1969; Studies on the prekallikrein (Kallikreinogen)- Kallikrein enzyme system of human plasma II. Evidence realting the kaolin-activated arginine esterase to plasma Kallikrein. Journal of Clinical Investigation 48: 23
• 4 Egeberg O. 1961; Assay of antihemophilic A, B and C factors by one-stage cephalin systems. Journal of Clinical and Laboratory Investigation 13: 140
• 5 Kasper CK, Whissell Buechy DY E, Aggeler PM. 1968; Hageman factor (factor XII) in an affected kindred and in normal adults. British Journal of Haematology 14: 140
• 6 Lucia JF, Ercoreca L, Torres M, Giralt M, Raichs A. 1979 Congenital deficiency of factor XII. A new family study. Thrombosis and Haemostasis. in press
• 7 Veltkamp JJ, Hemker HC, Loeliger EM. 1965; Detection of heterozygotes for factor VII, IX and XII deficiency. Thrombosis et Diathesis Haemorrhagica suppl (Suppl. 17) 18